A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

Clinical trial NCT05583526 · COMPLETED

Trial details

NCT number: NCT05583526
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Stable Nonsegmental Vitiligo Active Nonsegmental Vitiligo

Start date: 2022-12-01
Primary completion: 2026-02-05
Enrollment: 607

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.